Previsioni di mercato dei test sviluppati in laboratorio in Europa fino al 2028 - Impatto del COVID-19 e analisi regionale per tipologia (biochimica clinica, terapia intensiva, ematologia, microbiologia, diagnostica molecolare, immunologia e altri tipi di test) e applicazione (istituti accademici, organizzazioni di ricerca clinica, ospedali Laboratorio, Centri Diagnostici Specializzati e Altri)

Introduzione al mercato

Un test sviluppato in laboratorio (LDT) è un tipo di test diagnostico in vitro progettato e utilizzato all\'interno un unico laboratorio. Questi test possono essere utilizzati per stimare o distinguere un vasto assortimento di materiali di analiti come proteine, composti chimici come glucosio o colesterolo o DNA, da un campione ricevuto dall\'anatomia umana. Si prevede che l\'espansione dei metodi di diagnostica in vitro automatizzata (IVD) per laboratori e dispensari per eseguire analisi precise e prive di errori alimenterà l\'incremento.

Panoramica e dinamiche del mercato

Si prevede che il mercato europeo dei test sviluppati in laboratorio raggiungerà gli 8.988,78 milioni di dollari entro il 2028 da 5.664,43 milioni di dollari nel 2021; si stima che crescerà a un CAGR del 6,8% dal 2021 al 2028. La crescente incidenza di cancro e malattie genetiche e il crescente numero di lanci di prodotti in tutta Europa sono fattori che spingono il mercato dei test sviluppati in laboratorio. Tuttavia, il panorama normativo in evoluzione sta ostacolando la crescita del mercato dei test di sviluppo di laboratorio.

Gli LDT sono sviluppati e utilizzati all\'interno dei laboratori e non distribuiti o venduti ad altri laboratori o strutture sanitarie. Questi test sono progettati per superare la sfida dell’indisponibilità dei test commerciali. Molti LDT sono test genetici sviluppati per malattie rare. Pertanto, la frequenza di sviluppo e introduzione di nuovi LDT è elevata. Nel novembre 2020, Aditx Therapeutics, Inc ha ricevuto una certificazione CLIA per le operazioni di laboratorio AditxtScore per il monitoraggio immunitario, che ha consentito loro di lanciare il test AditxtScore per diagnosticare COVID-19. La crescente comparsa di varianti SARS-CoV-2 ha evidenziato la necessità di identificare, tracciare e tenere traccia delle mutazioni nell’intero genoma virale. Nel gennaio 2021 Eurofins ha lanciato il test NovaType per rilevare e monitorare nuove varianti di SARS-CoV-2. Questo test RT-PCR è clinicamente validato per identificare le varianti B.1.1.7 e B.1.351 in breve tempo. NovaType è già disponibile come LDT in Germania e sarà reso disponibile in oltre 50 laboratori Eurofins in tutto il mondo per testare i pazienti per COVID-19. Inoltre, la crescente domanda di medicina personalizzata offre significative opportunità di crescita per gli attori che operano nel mercato europeo dei test sviluppati in laboratorio.

I paesi di tutta Europa stanno assistendo a una recrudescenza del COVID-19 casi dopo aver mitigato con successo la pandemia. Molti paesi dichiarano ogni giorno più casi rispetto alla prima ondata del 2020. I governi di molti paesi stanno lavorando per aumentare la capacità di test, il che sta spingendo ulteriormente il mercato dei test sviluppati in laboratorio. Molti operatori del mercato hanno lanciato prodotti per soddisfare la crescente domanda. Ad esempio, nell’agosto 2020, Eurofins Technologies (Lussemburgo) ha lanciato una gamma di kit di test per il rilevamento di anticorpi basati sulla sierologia mediante ELISA di pazienti esposti a COVID-19. Questi test sono progettati per soddisfare i requisiti specifici della regione per COVID-19. Viracor Eurofins ha ricevuto la Food and Drug Administration (FDA) e l\'autorizzazione all\'uso di emergenza (EUA) per il suo test SARS-CoV-2 sviluppato in laboratorio. Altri laboratori Eurofins hanno sviluppato opzioni RT-PCR alternative per soddisfare gli obblighi normativi locali e mitigare i problemi della catena di fornitura dei reagenti a livello globale. Tuttavia, altri test non di emergenza hanno registrato un calo a causa delle misure di blocco e del sovraccarico delle istituzioni sanitarie.

Segmenti chiave del mercato

Il mercato europeo dei test sviluppati in laboratorio, per tipologia, è segmentato in biochimica clinica, terapia intensiva, ematologia, microbiologia, diagnostica molecolare, immunologia e altri tipi di test. Il segmento ematologico è stato suddiviso in coagulazione ed emostasi, test dell\'emoglobina, test dell\'emocromo e altri. Si prevede che il segmento della diagnostica molecolare deterrà la quota di mercato maggiore nel 2021. Tuttavia, si prevede che il segmento dell\'ematologia registrerà il CAGR più elevato durante il periodo di previsione.

Il laboratorio europeo ha sviluppato Il mercato dei test, per applicazione, è segmentato in istituti accademici, organizzazioni di ricerca clinica, laboratori ospedalieri, centri diagnostici specialistici e altri. Si prevede che il segmento dei laboratori ospedalieri deterrà la quota di mercato maggiore nel 2021. Tuttavia, si prevede che il segmento dei centri diagnostici specialistici registrerà il CAGR più elevato durante il periodo di previsione.

Principali fonti e aziende elencate

Alcune di le fonti primarie e secondarie a cui si fa riferimento durante la preparazione del rapporto sul mercato dei test sviluppati in laboratorio europeo sono l\'Associazione tedesca dell\'industria diagnostica (VDGH), la Deutsche Akkreditierungsstelle GmbH (DAkkS) e la Spanish Heart Foundation (FEC).

Motivi per acquistare il rapporto

Determinare potenziali aree di investimento sulla base di un\'analisi dettagliata delle tendenze del mercato dei test sviluppato in laboratorio in Europa nei prossimi anni.
Acquisire una conoscenza approfondita dei fattori sottostanti che guidano la domanda di diversi segmenti terapeutici per la dipendenza nei paesi con la maggiore spesa e identifica le opportunità offerte da ciascuno di essi.
Rafforza la tua conoscenza del mercato in termini di fattori trainanti della domanda, tendenze del settore e ultimi sviluppi tecnologici, tra gli altri.
Identificare i principali canali che guidano il mercato europeo del diltiazem, fornendo un quadro chiaro delle opportunità future che aiuterà ad analizzare, con conseguente espansione delle entrate.
Canalizzare le risorse concentrandosi sui programmi in corso intrapresi dai diversi paesi all\'interno del Mercato dei test sviluppato in laboratorio in Europa.

SEGMENTAZIONE DEL MERCATO DI TEST SVILUPPATO DA UN LABORATORIO IN EUROPA

Per tipo

Biochimica clinica
Area critica
Ematologia

- Coagulazione ed emostasi,
- Test dell\'emoglobina
- Emocromo
- Altro

Immunologia
Microbiologia
Diagnostica molecolare
Altri tipi di test

Per applicazione

Istituti accademici
Organizzazioni di ricerca clinica
Laboratori ospedalieri
Specialità Centri diagnostici
Altri

Per paese

Profili aziendali

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Laboratory Developed Test Market – By Type

1.3.2 Europe Laboratory Developed Test Market – By Application

1.3.3 Europe Laboratory Developed Test Market – By Country

2. Laboratory Developed Test Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Laboratory Developed Test Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe– PEST Analysis

4.3 Experts Opinion

5. Laboratory Developed Test Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Incidence of Cancer and Genetic Disorders

5.1.2 Large Number of Product Launches

5.2 Market Restraints

5.2.1 Changing Regulatory Landscape

5.3 Market Opportunities

5.3.1 Continuous Research on Personalized Medicine

5.4 Future Trends

5.4.1 Automation of Laboratory Processes

5.5 Impact Analysis

6. Laboratory Developed Test Market –Europe Analysis

6.1 Europe Laboratory Developed Test Market Revenue Forecast and Analysis

7. Laboratory Developed Test Market Analysis – By Type

7.1 Overview

7.2 Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)

7.3 Clinical Biochemistry

7.3.1 Overview

7.3.2 Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Haematology

7.4.1 Overview

7.4.2 Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3 Coagulation and Hemostasis

7.4.3.1 Overview

7.4.3.2 Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4 Hemoglobin Testing

7.4.4.1 Overview

7.4.4.2 Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5 Blood Count Testing

7.4.5.1 Overview

7.4.5.2 Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.6 Others

7.4.6.1 Overview

7.4.6.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Immunology

7.5.1 Overview

7.5.2 Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Critical Care

7.6.1 Overview

7.6.2 Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Microbiology

7.7.1 Overview

7.7.2 Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.8 Molecular Diagnostics

7.8.1 Overview

7.8.2 Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.9 Other Test Types

7.9.1 Overview

7.9.2 Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8. Laboratory Developed Test Market Analysis – By Application

8.1 Overview

8.2 Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)

8.3 Academic Institutes

8.3.1 Overview

8.3.2 Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Clinical Research organizations

8.4.1 Overview

8.4.2 Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Hospital laboratory

8.5.1 Overview

8.5.2 Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Specialty Diagnostic Centers

8.6.1 Overview

8.6.2 Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

9. Laboratory Developed Test Market – Europe Analysis

9.1 Europe: Laboratory Developed Test Market

9.1.1 Overview

9.1.3 Europe: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)

9.1.3.1 Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.1.1 Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.1.2 Germany: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.1.2.1 Germany: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.1.3 Germany: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.2 France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.1 France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.2 France: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.2.2.1 France: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.2.3 France: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.3 UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.3.1 UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.3.2 UK: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.3.2.1 UK: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.3.3 UK: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.4 Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.4.1 Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.4.2 Italy: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.4.2.1 Italy: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.4.3 Italy: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.5 Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.5.1 Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.5.2 Spain: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.5.2.1 Spain: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.5.3 Spain: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.6 Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.6.1 Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.6.2 Rest of Europe: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.6.2.1 Rest of Europe: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.6.3 Rest of Europe: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

10. Impact Of COVID-19 Pandemic on Laboratory Developed Test Market

10.1 Europe: Impact Assessment of COVID-19 Pandemic

11. Laboratory Developed Test Market–Industry Landscape

11.1 Overview

11.2 Inorganic Growth Strategies

11.2.1 Overview

11.3 Organic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Quest Diagnostics Incorporated

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 F.HOFFMANN-LA ROCHE LTD.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 QIAGEN

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Illumina, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Eurofins Scientific

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.7 Guardant Health

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. Germany: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 2. Germany Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 3. Germany: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4. France: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 5. France Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 6. France: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 7. UK: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 8. UK Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 9. UK: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 10. Italy: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 11. Italy Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 12. Italy: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 13. Spain: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 14. Spain Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 15. Spain: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16. Rest of Europe: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 17. Rest of Europe Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 18. Rest of Europe: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19. Recent Inorganic Growth Strategies in the Laboratory Developed Test Market

Table 20. Recent Organic Growth Strategies in the Laboratory Developed Test Market

Table 21. Glossary of Terms, Laboratory Developed Test Market

LIST OF FIGURES

Figure 1. Laboratory Developed Test Market Segmentation

Figure 2. Laboratory Developed Test Market Segmentation, By Country

Figure 3. Europe Laboratory Developed Test Market Overview

Figure 4. Molecular Diagnostics Segment Held the Largest Share of the Type Segment in Laboratory Developed Test Market

Figure 5. Europe Laboratory Developed Test Market – Leading Country Markets (US$ Million)

Figure 6. Europe and PEST Analysis

Figure 1. Laboratory Developed Test Market Impact Analysis of Drivers and Restraints

Figure 2. Europe Laboratory Developed Test Market – Revenue Forecast and Analysis – 2020- 2028

Figure 3. Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)

Figure 4. Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 5. Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 6. Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 7. Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 8. Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 9. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)

Figure 16. Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Europe: Laboratory Developed Test Market, by Key Country – Revenue (2021) (USD Million)

Figure 22. Europe: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)

Figure 23. Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 24. France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 25. UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 26. Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 27. Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 28. Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 29. Impact of COVID-19 Pandemic in European Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe laboratory developed test market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe laboratory developed test market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample